April 5, 2021
Mayo Clinic Research in the news — 4/5/2021
Mayo Clinic research and faculty experts were featured in a variety of news stories including 3D printed surgical models, early treatment for smoldering multiple myeloma, and heart attacks in women. Updated guideline highlights new therapies, considerations in anaplastic thyroid cancer Healio, 4/1/2021 An updated guideline for best practices in managing anaplastic thyroid cancer stresses the […]
Tags: 3D printing, Alfredo Quinones-Hinojosa, Alzheimer's disease, artificial intelligence, blood cancer, chronic kidney disease, Clifford Jack Jr., COVID-19, digital health, Eric Moore, genetic testing, genetics
August 26, 2020
Mayo Clinic Research in the news — 8/26/2020
Although it hasn’t even been a week, many news outlets have featured Mayo Clinic Research and our research experts in articles across a broad range of topics. In order not to overload – it really is shaping up to be an interesting week – we’ll save COVID-related news for another day. Read on to hear […]
Tags: Allisa Song, Alzheimer's disease, animal model, Clifford Jack Jr., dogs, fibromyalgia, hypertension, liver disease, Mayo Clinic Alix School of Medicine, Mayo Clinic Proceedings, medical research education, menopause
August 14, 2020
Mayo Clinic Research in the news 8/14/2020
While much of the news around health care research is COVID-19 related, Mayo Clinic researchers are hard at work across the entire spectrum of health and health care delivery. Our multidisciplinary research teams are seeking ways to improve outcomes, lower costs and enhance the experience of patients, providers and caregivers. Read on for snippets of […]
Tags: aging, Andrew Badley, antibodies, breast cancer, chemotherapy, Clifford Jack Jr., clinical research, clinical trials, COVID-19, Devon Rubin, Eugenia Trushina, Grzegorz Nowakowski
July 10, 2019
Biomarkers could help early diagnosis of Alzheimer’s
By Advancing the Science contributor
Early diagnosis will ultimately be essential in the management and treatment of Alzheimer’s disease. Examination of Alzheimer’s biomarkers can improve the prediction of short-term memory decline in middle-age and elderly individuals, according to new research led by Mayo Clinic.
Tags: Alzheimer's disease, biomarkers, Clifford Jack Jr., Mayo Clinic Study of Aging, Rochester Epidemiology Project